[628] USE OF LOW-DOSE PEGINTERFERON a-2a (40 kD) (PEGASYS®) TO TREAT HEPATITIS C-INFECTED END-STAGE RENAL DISEASE PATIENTS UNDERGOING HAEMODIALYSIS: INTERIM RESULTS FROM A RANDOMISED STUDY
Saved in:
| Title: | [628] USE OF LOW-DOSE PEGINTERFERON a-2a (40 kD) (PEGASYS®) TO TREAT HEPATITIS C-INFECTED END-STAGE RENAL DISEASE PATIENTS UNDERGOING HAEMODIALYSIS: INTERIM RESULTS FROM A RANDOMISED STUDY |
|---|---|
| Authors: | Peck-Radosavljevic, M., Boletis, J., Besisik, F., Lucia Ferra, M., Alric, L., Samuel, D., Messinger, D., Junker, H., Cheinquer, H. |
| Source: | Journal of Hepatology. Apr2007, Vol. 46, pS237-S238. 0p. |
| Database: | Academic Search Ultimate |
| ISSN: | 01688278 |
|---|---|
| DOI: | 10.1016/S0168-8278(07)62226-0 |